R&D Expensing Is Back: How OBBBA Changes the Cash-Flow Line for Innovative Businesses
For the last few years, the tax code has acted like a pace car for innovation.
Businesses were spending real money on engineering, software development, product testing, manufacturing improvements, process design, and other research activities, but the tax deduction was forced into slow motion. Under the prior TCJA rules, domestic research and experimental costs generally had to be capitalized and amortized over five years. Foreign research costs were amortized over fifteen years.
That meant cash went out today, but the deduction came back in pieces. Wonderful, if your business enjoys lending money to the federal government at zero interest while trying to fund growth, payroll, inventory, and equipment.
Now the pace car is off the track.
The One Big Beautiful Bill Act, commonly called OBBBA, restored current expensing for many domestic research and experimental expenditures for tax years beginning after December 31, 2024. The new law added IRC Section 174A, which generally allows taxpayers to deduct domestic R&E costs in the year paid or incurred. Foreign R&E costs remain subject to 15-year amortization.
That is not just a tax change. It is a cash-flow planning opportunity. And like most tax opportunities, it comes with just enough technical complexity to make sure nobody gets too comfortable.
1 Domestic R&D Expensing Is Back
For calendar-year businesses, the big headline is simple:
Beginning in 2025, qualifying domestic research and experimental costs may generally be deducted immediately.
That includes many costs tied to developing or improving products, processes, formulas, prototypes, software, manufacturing methods, or technical capabilities. The IRS guidance also confirms that software development costs are treated as research or experimental expenditures for Section 174A purposes.
This matters because deductions affect cash flow. A business investing $500,000 into qualifying domestic R&E may no longer need to wait five years to recover that deduction for federal tax purposes. Instead, the deduction may be available currently, assuming the costs qualify and are properly documented.
That can improve:
- Current-year taxable income
- Cash tax planning
- Reinvestment capacity
- Lending and covenant discussions
- Pricing decisions
- Partner or shareholder distribution planning
- Forecasting and valuation models
In CFO language, this changes the timing of cash. And timing of cash is often the difference between “strategic reinvestment” and “why is everyone yelling on Tuesday?”
2 Foreign R&D Still Runs a Longer Lap
The new rules are favorable for domestic R&E, but they do not fully restore immediate expensing for foreign research. Foreign research and experimental expenditures generally remain capitalized and amortized over fifteen years.
That means companies with engineers, developers, technical teams, or contract research outside the United States need to separate domestic and foreign costs carefully. This is not just bookkeeping trivia. It can materially change the tax result.
A company with $800,000 of R&E spending may have a very different deduction depending on whether that work was performed in Arizona, California, Texas, Mexico, India, Eastern Europe, or some delightful mystery location buried in a contractor invoice labeled “technical services.”
THE CFO TAKEAWAY Location matters. Documentation matters. Cost classification matters.
3 The 2022 Through 2024 Backlog May Be Recoverable Faster
Many businesses capitalized domestic R&E costs during 2022, 2023, and 2024 under the TCJA-required amortization rules. OBBBA gives taxpayers a transition option for those remaining unamortized domestic R&E amounts.
In general, taxpayers may elect to deduct the remaining unamortized domestic R&E balance either:
- Option 1: Entirely in the first tax year beginning after December 31, 2024 (2025 for calendar-year taxpayers).
- Option 2: Ratably over two tax years beginning with the first tax year after December 31, 2024 (Spreading it over 2025 and 2026).
This is where the CFO work begins.
The biggest deduction is not automatically the best answer. A business needs to model the result. A full 2025 deduction may be attractive if the company has strong taxable income, high current tax exposure, or immediate cash-flow needs. But spreading the deduction over two years may produce a better result if income is expected to rise in 2026, if deductions would create or deepen an NOL, or if other limitations reduce the value of the deduction.
Tax deductions are like horsepower. Useful, but not if you spin the tires into a wall.
4 Small Businesses May Have a Retroactive Opportunity
OBBBA includes a special opportunity for eligible small business taxpayers. For 2025, a small business taxpayer generally means a taxpayer, other than a tax shelter, that meets the Section 448(c) gross receipts test. The inflation-adjusted threshold for a taxable year beginning in 2025 is $31 million in average annual gross receipts.
Eligible taxpayers may be able to apply the new domestic R&E expensing rules retroactively to tax years beginning after December 31, 2021 and before January 1, 2025. That may involve amending affected returns or applying approved accounting method procedures.
CRITICAL DEADLINE: The election generally must be made by July 6, 2026 (because the statutory one-year deadline falls on July 4, 2026, which is a Saturday).
For the right business, this can unlock refunds from prior years. But this is not a “click button, receive money” situation. Prior-year refunds can affect state returns, partner or shareholder reporting, amended K-1s, basis calculations, credit limitations, and possibly banking or investor reporting.
The Strategic Question
“Can we amend?”
“Should we amend, and what are all the downstream effects?”
That is where the telemetry matters.
5 Watch Section 280C Coordination With the R&D Credit
Businesses claiming the Section 41 R&D tax credit need to pay close attention to Section 280C.
OBBBA amended Section 280C so that domestic R&E expenditures otherwise deducted or capitalized are reduced by the amount of the Section 41 research credit. Alternatively, taxpayers may elect to take a reduced research credit instead of reducing the deduction or capitalized amount. That election must generally be made on a timely filed return, including extensions, and is irrevocable.
You generally do not get to claim the full R&D credit and the full related deduction without coordination. The tax code saw that idea coming and threw caltrops on the road.
This is one of the most important planning points in the new R&E environment. The best answer may depend on the company’s taxable income, credit position, entity structure, state tax impact, future profitability, and whether the business is using credits currently or carrying them forward.